The International Myeloma Working GroupTM (IMWG) stands as a premier global collaborative of myeloma specialists, bringing together 345 leading researchers and clinicians from 43 countries. This extraordinary panel represents the forefront of multiple myeloma research, treatment, and innovation.
The IMWG represents a critical international network dedicated to advancing multiple myeloma understanding, developing cutting-edge treatments, and improving patient outcomes through collaborative research and shared expertise.
This roster reflects the collaborative spirit of modern medical research, demonstrating how global cooperation can drive medical innovation and progress in understanding and treating complex diseases like multiple myeloma.
| Name | Country | Institution |
|---|---|---|
| Nadine Abdallah MD Mayo Clinic - Rochester, MN United States | United States | Mayo Clinic - Rochester, MN |
| Hikmat Abdel-Razeq MD King Hussein Cancer Center Jordan | Jordan | King Hussein Cancer Center |
| Masahiro Abe MD; PhD Tokushima University Japan | Japan | Tokushima University |
| Niels Abildgaard MD Odense University Hospital Denmark | Denmark | Odense University Hospital |
| Rafat Abonour MD IU Health University Hospital United States | United States | IU Health University Hospital |
| Ingerid Abrahamsen M.D, PhD Oslo University Hospital Norway | Norway | Oslo University Hospital |
| Aimaz Afrough MD University of Texas Southwestern Medical Center United States | United States | University of Texas Southwestern Medical Center |
| Sikander Ailawadhi MD Mayo Clinic United States | United States | Mayo Clinic |
| Melissa Alsina MD Moffitt Cancer Center United States | United States | Moffitt Cancer Center |
| Kenneth Anderson MD Dana-Farber Cancer Institute United States | United States | Dana-Farber Cancer Institute |
| Larry Anderson MD, PhD UT Southwestern Medical Center United States | United States | UT Southwestern Medical Center |
| Frida Askeland MD Oslo University Hospita Norway | Norway | Oslo University Hospita |
| Shebli Atrash MD, MS, FACP Levine Cancer Institute United States | United States | Levine Cancer Institute |
| Herve Avet-Loiseau MD Institut universitaire du cancer de Toulouse Oncopole France | France | Institut universitaire du cancer de Toulouse Oncopole |
| Ashraf Badros MD University of Maryland United States | United States | University of Maryland |
| Nizar Bahlis MD University of Calgary - Arnie Charbonneau Cancer Institute Canada | Canada | University of Calgary - Arnie Charbonneau Cancer Institute |
| Susan Bal MD University of Alabama at Birmingham United States | United States | University of Alabama at Birmingham |
| Rahul Banerjee MD Fred Hutchinson Cancer Center United States | United States | Fred Hutchinson Cancer Center |
| Linda Baughn PhD Mayo Clinic United States | United States | Mayo Clinic |
| Rachid Baz MD H. Lee Moffitt Cancer Center and Research Institute United States | United States | H. Lee Moffitt Cancer Center and Research Institute |
| Meral Beksac MD Istinye University Ankara Liv Hospital Turkey | Turkey | Istinye University Ankara Liv Hospital |
| Dina Ben-Yehuda MD Hadassah Medical Center, Faculty of Medicine Hebrew University Jerusalem Israel Israel | Israel | Hadassah Medical Center, Faculty of Medicine Hebrew University Jerusalem Israel |
| William Bensinger MD Swedish Cancer Institute United States | United States | Swedish Cancer Institute |
| Jesús Berdeja MD Sarah Cannon Research Institute United States | United States | Sarah Cannon Research Institute |
| P. Leif Bergsagel MD Mayo Clinic United States | United States | Mayo Clinic |